Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
連絡先
得意分野
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Lawyers Jaime Jones, Jennifer Saulino, and Lisa Miller to Speak at the ABA′s 2026 Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C.Wednesday, May 27, 2026 – Thursday, May 28, 2026Vice President and CMS Announce Suite of New Administrative Actions to Further Federal Anti-Fraud Health Care InitiativesMay 20, 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Tariff Enforcement at the Forefront: Importer Agrees to Pay $549.5 million in Largest-Ever Trade-Related False Claims Act SettlementMay 18, 2026Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

